Fatal Diabetic Ketoacidosis Induced by Capivasertib (Truqap) in a Patient with Metastatic Breast Cancer: A Case Report

2026 Preprint Open access

Read full text
Authors: Anid Hassan, Samiul haque, Mohaimenul islam, Aroob Farooqi, javeria gul, Kamil Ahmad Kamil, Michael J. Levitt, Mohammad Hossain
DOI: 10.22541/au.177063331.15797811/v1
Cited by: 0

Abstract

Capivasertib is capable of precipitating lethal diabetic ketoacidosis in patients with or without a history of diabetes.Early hyperglycemia after drug initiation should be considered a medical emergency and treated

Fields of Study & Subjects

Advanced Breast Cancer Therapies PI3K/AKT/mTOR signaling in cancer Metabolism Diabetes and Cancer

Publication details

Publication date
9 February 2026
Language
EN
Document type
Preprint